Health Care & Life Sciences » Biotechnology | Cara Therapeutics Inc.

Cara Therapeutics Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
12,357.00
52,663.00
106,741.00
58,976.00
92,569.00
161,744
Total Accounts Receivable
61.00
200.00
464.00
939.00
854.00
1,590
Other Current Assets
2,140.00
287.00
1,729.00
1,530.00
1,635.00
4,805
Total Current Assets
14,558.00
53,150.00
108,934.00
61,445.00
95,058.00
168,139
Net Property, Plant & Equipment
2,825.00
2,084.00
1,263.00
1,614.00
1,177.00
880
Total Investments and Advances
700.00
700.00
700.00
769.00
769.00
21,804
Total Assets
18,083.00
55,934.00
110,897.00
63,828.00
97,004.00
190,823
Accounts Payable
676.00
515.00
1,965.00
4,738.00
3,829.00
Other Current Liabilities
4,757.00
2,883.00
3,303.00
6,795.00
4,677.00
Total Current Liabilities
5,433.00
3,398.00
5,268.00
11,533.00
8,506.00
Other Liabilities
1,139.00
874.00
585.00
1,570.00
1,718.00
Total Liabilities
6,572.00
4,272.00
5,853.00
13,103.00
10,224.00
Common Equity (Total)
54,075.00
51,662.00
105,044.00
50,725.00
86,780.00
Total Shareholders' Equity
11,511.00
51,662.00
105,044.00
50,725.00
86,780.00
Total Equity
11,511.00
51,662.00
105,044.00
50,725.00
86,780.00
Liabilities & Shareholders' Equity
18,083.00
55,934.00
110,897.00
63,828.00
97,004.00
Preferred Stock (Carrying Value)
65,586.00
-
-
-
-

About Cara Therapeutics

View Profile
Address
4 Stamford Plaza
Stamford Connecticut 06902
United States
Employees -
Website http://www.caratherapeutics.com
Updated 07/08/2019
CARA Therapeutics, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T.